Will Science Ever Marry Technology?

The value to the life sciences of collaboration between the great scientific minds of pharma and the great engineering minds of the analytics industry, especially as related to the pandemic, and the potential benefits offered by a global clinical neural network that would accelerate COVID-19 therapies, as well as drugs for other diseases.

Moderator: Taren Grom

 

Panelists

  • Suresh Kaata, Founder and CEO, Saama Technologies, 2018 PharmaVOICE 100

  • Sagar Anisingaraju, Chief Strategy Officer, Saama Technologies, 2020 PharmaVOICE 100

  • Elliot Barnathan, M.D., FACC, FAHA, Senior Director, Cardiovascular Clinical Development, Janssen Research & Development, 2019 PharmaVOICE 100

  • Jay Kaminski, Advisor, Health2047 Inc.

  • Clive Meanwell, M.D., Ph.D., Founder, The Medicines Company, 2016 PharmaVOICE 100

 RECORDING 

SPONSOR

CONTACT /

WHEN /

WHERE /

September 10, 2020

12:00am-11:59pm EDT

pharmavoice100.com

© 2020 by PharmaVOICE

Feedback2.png